Super absorption Coenzyme Q.sub.10
An improved soft gelatin formulation and process methodology that increases single Coenzyme Q.sub.10 molecules presented to the absorption channels of the small intestines by providing medium chain triglycerides, Vitamin E and natural beta carotene to Coenzyme Q.sub.10 in a soft gel capsule to increase the absorption thereof.
Patent Number: 7,273,622 | Patent Date: 09/25/2007
Solubilized CoQ-10 and carnitine
The present invention is directed to compositions and methods of delivery of CoQ-10 and an amino acid solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 and the amino acid, such as carnitine, i.e., carnitine tartrate, in formulations, such as soft gel capsules.
Patent Number: 7,273,606 | Patent Date: 09/25/2007
Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
A formulation of Coenzyme Q.sub.10, beta-carotenes, Vitamin E, and medium chain triglycerides in rice bran oil and an optional thickener, such as bee's wax, is provided in a soft gel capsule so that a maximum of the Coenzyme Q.sub.10 is absorbed by the human body. Generally, about 60 mg of Coenzyme Q.sub.10 is the normal amount provided daily to a healthy sedentary adult.
Patent Number: 7,220,429 | Patent Date: 05/22/2007
Solubilized CoQ-10 and carnitine
The present invention is directed to compositions and methods of delivery of CoQ-10 and an amino acid solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 and the amino acid, such as carnitine, i.e., carnitine tartrate, in formulations, such as soft gel capsules.
Patent Number: 7,169,385 | Patent Date: 01/30/2007
Super absorption Coenzyme Q.sub.10
An improved soft gelatin formulation and process methodology that increases single Coenzyme Q.sub.10 molecules presented to the absorption channels of the small intestines by providing medium chain triglycerides, Vitamin E and natural beta carotene to Coenzyme Q.sub.10 in a soft gel capsule to increase the absorption thereof.
Patent Number: 7,060,263 | Patent Date: 06/13/2006
Formulation to enhance antioxidant potency of Vitamin E
A formulation to deliver a full-spectrum of Vitamin E isomers for improved antioxidant capacity, bioavailability, dissolution and efficacy. The formulation includes dl-.alpha.-tocopheryl acetate or dl-.alpha.-tocopheryl succinate (synthetic Vitamin E), natural Vitamin E and mixed tocopherols, such as .alpha.-, .beta.-, .gamma.- and .delta.-tocopherol, as well as four isomers (.alpha., .beta., .gamma. and .delta.) of tocotrienols. This formulation is designed to deliver at least 17-times the antioxidant capacity of synthetic Vitamin E (dl-.alpha.-tocopheryl acetate), and at least twice the antioxidant capacity of natural Vitamin E (d-.alpha.-tocopherol) as measured by oxygen radical absorbance capacity (ORAC) assay. The potent antioxidant capacity of this formula affords protection against oxidative damage of cell membranes, heart disease, cancer and eye and skin disease.
Patent Number: 7,015,245 | Patent Date: 03/21/2006
Formulation and delivery method to enhance antioxidant potency of Vitamin E
A formulation to deliver a full-spectrum of Vitamin E isomers for improved antioxidant capacity, bioavailability, dissolution and efficacy. The formulation includes dl-.alpha.-tocopheryl acetate or dl-.alpha.-tocopheryl succinate (synthetic Vitamin E), natural Vitamin E and mixed tocopherols, such as .alpha.-, .beta.-, .gamma.- and .delta.-tocopherol, as well as four isomers (.alpha., .beta., .gamma. and .delta.) of tocotrienols. This formulation is designed to deliver at least 17-times the antioxidant capacity of synthetic Vitamin E (dl-.alpha.-tocopheryl acetate), and at least twice the antioxidant capacity of natural Vitamin E (d-.alpha.-tocopherol) as measured by oxygen radical absorbance capacity (ORAC) assay. The potent antioxidant capacity of this formula affords protection against oxidative damage of cell membranes, heart disease, cancer and eye and skin disease.
Patent Number: 7,012,092 | Patent Date: 03/14/2006
Hyaluronic acid in soft gel form
An orally administered soft gelatin formulation preparation of low molecular weight Hyaluronic Acid (HA) for use as a nutritional supplement to provide the primary benefit of internally causing the softening of the human skin.
Patent Number: 7,008,932 | Patent Date: 03/07/2006
Coenzyme Q10 formulation and process methodology for softgel capsules manufacturing
A formulation of Coenzyme Q.sub.10, beta-carotenes, Vitamin E, and medium chain triglycerides in rice bran oil and an optional thickener, such as bee's wax, is provided in a soft gel capsule so that a maximum of the Coenzyme Q.sub.10 is absorbed by the human body. Generally, about 60 mg of Coenzyme Q.sub.10 is the normal amount provided daily to a healthy sedentary adult.
Patent Number: 6,955,820 | Patent Date: 10/18/2005
Formulation and manufacturing process for coenzyme Q10 soft gel capsules
A soft gelatine capsule formulation for improved manufacturing of Coenzyme Q10, comprising Coenzyme Q10 in a thixatropic gelatine carrier capable of admixing without heating with Coenzyme Q10, and capable of keeping Coenzyme Q10 in suspension at ambient temperature.
Patent Number: 6,855,733 | Patent Date: 02/15/2005
Hyaluronic Acid in soft gel form way cool
An orally administered soft gelatin formulation preparation of low molecular weight Hyaluronic Acid (HA) for use as a nutritional supplement to provide the primary benefit of internally causing the softening of the human skin.
Patent Number: 6,806,259 | Patent Date: 10/19/2004
Corosolic acid formulation and its application for weight-loss management and blood sugar balance
A soft gelatin capsule and method to deliver an efficable dose of Lagerstroemia speciosa L. (marketed by Soft Gel Technologies under the trademark Glucosol.TM.) for the assistance and maintenance of moderate weight loss through blood sugar maintenance. The product relies on the effects of corosolic acid on blood sugar levels to derive a healthy weight loss effect for Type II diabetics (non-insulin dependent) and healthy non-diabetics and the improved absorption of an oil based delivery system. The product provides safe and sustainable weight loss when combined with a restricted calorie diet and regular exercise. Its benefits include improvement of cardiovascular health, normalized blood sugar levels, and improved physical appearance with the positive psychological effects associated with successful and safe weight loss/maintenance.
Patent Number: 6,784,206 | Patent Date: 08/31/2004
